English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/166633
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan

AuthorsBäuerl, Christine ; Collado, María Carmen ; Diaz Cuevas, Ana; Viña, José; Pérez Martínez, Gaspar
KeywordsDisease processes
Microbial structure
Markers
Intestinal microbiology
Indicators
Issue Date25-Mar-2018
PublisherJohn Wiley & Sons
CitationLetters in Applied Microbiology 66(6): 464-471 (2018)
AbstractAlzheimer's disease (AD) is the most common form of dementia and one of the major causes of disability and dependency in older people. Accumulating evidences link gut microbiota with different diseases and its relationship with neurodegenerative diseases is becoming most intriguing. This study was aimed to compare the gut microbiota of transgenic APP/PS1 (TG) mice, a well‐established deterministic mouse model of AD, with their C57BL/6 wild‐type (WT) littermates. Faecal samples were collected from 3‐, 6‐ and 24‐month‐old mice and analysed by pyrosequencing of the V1–V3 region of the bacterial 16S rRNA genes. Bacterial profiles were similar in all young mice (3 months old), and started to diverge so that 6‐month‐old WT and TG mice had different and more diverse microbiota. During ageing, Turicibacteriaceae (typical mice bacterial group) and Rikenellaceae increased in all groups, although total Bacteroidetes remained stable. TG mice were characterized by an increase in Proteobacteria after 6 months, particularly the genus Sutterella (Betaproteobacteria), interestingly also increased in autism disorder. Also, the inflammation related family Erysipelotrichaceae was more abundant in TG mice at 24 months compared to wild‐type control. In summary, AD pathology in mice shifts the gut microbiota towards profiles that share features with autism and inflammatory disorders.
Publisher version (URL)https://doi.org/10.1111/lam.12882
URIhttp://hdl.handle.net/10261/166633
DOI10.1111/lam.12882
E-ISSN1472-765X
Appears in Collections:(IATA) Artículos
Files in This Item:
File Description SizeFormat 
Bauerl LAM 2018.pdfArtículo principal1,49 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.